Zhejiang Shapuaisi Pharmaceutical Co., Ltd. provided earnings guidance for the third quarter ended Sep. 2016. For the period, the company predicts the net profit owned by shareholders of the listed company to be between RMB 202 million and RMB 212 million, a year-on-year increase of between 58% and 66%.